Waterfront Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Waterfront Wealth's JAZZ Position: Q3 2026 in Review
Waterfront Wealth reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.36% in Q3 2026, selling an estimated $13.8K and leaving 15,479 shares worth $3.31M. The position accounts for 0.53% of the portfolio, ranked #58.
Waterfront Wealth first reported a position in JAZZ in Q1 2022 and has held it in 19 quarters since. The position peaked at $3.79M in Q2 2026. 277 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Waterfront Wealth held 15,479 shares of Jazz Pharmaceuticals worth $3.31M as of Q3 2026.
- Waterfront Wealth sold 56 Jazz Pharmaceuticals shares in Q3 2026, an estimated $13.8K.
- Jazz Pharmaceuticals made up 0.53% of Waterfront Wealth's portfolio in Q3 2026, its #58 holding.
- Waterfront Wealth first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 19 quarters since.
- Waterfront Wealth's Jazz Pharmaceuticals position peaked at $3.79M in Q2 2026.
- 277 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Waterfront Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.